Osimertinib
Osimertinib-related pneumonitis incidence higher in real-world lung cancer population
Drug-related pneumonitis occurred among 18% of patients receiving osimertinib for advanced epidermal growth factor receptor mutation-positive non-small cell lung cancer, according to study results published in CHEST.
VIDEO: Recognizing importance of CNS penetration in EGFR-mutated lung cancer
In this video, Ravi Salgia, MD, PhD, highlighted two studies that investigated treatment for EGFR-mutated non-small cell lung cancer presented at ASCO Annual Meeting.
VIDEO: Challenges in treating EGFR-mutated lung cancer
In this video, Erminia Massarelli, MD, PhD, MS, co-director of the lung cancer and thoracic oncology program, and associate professor in the department of medical oncology and therapeutics research at City of Hope Cancer Center in Duarte, California, discusses challenges in treating EGFR-mutated lung cancer.
VIDEO: Treating lung cancer with EGFR exon 20 mutation
In this video, Erminia Massarelli, MD, PhD, MS, co-director of the lung cancer and thoracic oncology program, and associate professor in the department of medical oncology and therapeutics research at City of Hope Cancer Center in Duarte, California, discusses treatment variations for rarer mutations such as EGFR exon 20 insertions.
VIDEO: Treatment options for early-stage EGFR-mutated non-small cell lung cancer
In this video, Erminia Massarelli, MD, PhD, MS, co-director of the lung cancer and thoracic oncology program, and associate professor in the department of medical oncology and therapeutics research at City of Hope Cancer Center in Duarte, California, highlights treatment options for EGFR-mutated lung cancer.
VIDEO: Disparities in care, management of EGFR-mutated lung cancer
In this video, Erminia Massarelli, MD, PhD, MS, co-director of the lung cancer and thoracic oncology program, and associate professor in the department of medical oncology and therapeutics research at City of Hope Cancer Center in Duarte, California, highlights disparities that exist in the treatment.
VIDEO: ILCC panel discusses osimertinib in practice, impact of ADAURA data
In this video, David R. Gandara, MD, spoke with Healio about discussions surrounding the ADAURA trial held at the 22nd annual International Lung Cancer Congress.
VIDEO: ASCO presentation addresses area of unmet need in EGFR-positive NSCLC
Nathan A. Pennell, MD, PhD, spoke with Healio about a presentation focused on patients with EGFR-positive non-small cell lung cancer who have relapsed with osimertinib.
VIDEO: Cost-effectiveness analyses of adjuvant osimertinib uses data from ADAURA trial
In this video, Nathan A. Pennell, MD, PhD, spoke with Healio about a study he co-authored that was presented at virtual ASCO Annual Meeting.